Simplify Logo

Full-Time

Director – Clinical Scientist

Posted on 3/22/2024

Verve Therapeutics

Verve Therapeutics

201-500 employees

Developing gene editing therapies for heart disease

Hardware
Biotechnology
Healthcare

Senior

Cambridge, MA, USA

Category
Healthcare Administration & Support
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Communications
Requirements
  • Advanced degree in life sciences (PhD, MD or both)
  • Experience with the development of key clinical study documents
  • Experience with the analysis and review of clinical data
  • Working knowledge of biostatistics, GCP, and regulatory requirements for clinical studies
  • Track record of working with and managing CROs and external vendors
  • Strong attention to detail and organizational skills
  • Exceptional verbal and written communication skills
  • Ability to build strong relationships and work effectively with cross-functional teams
Responsibilities
  • Review, analyze, and interpret emerging clinical trial data
  • Lead preparation for key study meetings
  • Partnership with the medical monitor on oversight of clinical trial activities
  • Liaison role with the broader clinical development team
  • Contribution to authoring key study and regulatory documents
  • Leadership in internal meetings and review topics
  • Collaborate with clinical and research teams to implement the clinical biomarker strategy
  • Ensuring compliance with ICH/GCP guidelines and applicable regulatory requirements
  • Contribution to the development of presentations, abstracts, and publications
  • Other duties as assigned

Verve Therapeutics is developing single-course gene editing medicines to address cardiovascular disease, with a focus on precision genetic editing technologies to lower LDL cholesterol and triglyceride levels. Their lead program, VERVE-101, targets heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease.

Company Stage

IPO

Total Funding

$419.3M

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

7%

1 year growth

5%

2 year growth

54%
INACTIVE